On 1 October, infertility treatment clinic Invicta implemented a new AI tool – the AIOO application, which was co-created by MIM Solutions. AlOO predicts the likely number of mature ova obtainable during the in-vitro process. The solution, which is powered by artificial intelligence, bases its prognosis on the patient’s individual laboratory test results and her treatment history.
Together with the application, INVICTA has created a test that allows the assessment of a patient’s genetic predisposition. The test makes AIOO’s prognosis of the number of mature oocytes even more accurate.
Events
Should you be afraid of AI Act?
Do you know what The AI Act is? Are you afraid what changes it will bring to you and your company? Do you want to
